ArticleNeuroradiology2026
Peak width of skeletonized mean diffusivity as a quantitative imaging marker of white matter alterations in MRI-negative temporal lobe epilepsy: validation with demographic covariate adjustment.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThis study evaluated the peak width of skeletonized mean diffusivity (PSMD) as a quantitative imaging marker in patients with magnetic resonance imaging-negative (MRI-negative) temporal lobe epilepsy (TLE), accounting for age and sex effects.
methodsThis retrospective study included 34 MRI-negative TLE patients and 40 age- and sex-matched healthy controls (HCs). PSMD was calculated using tract-based spatial statistics and histogram analysis. Hierarchical regression identified PSMD determinants. Receiver operating characteristic analysis compared uncorrected and age- and sex-corrected PSMD, with the latter validated by 10-fold cross-validation.
resultsPSMD was significantly elevated in patients versus HCs (2.545 × 10
conclusionPSMD is a quantitative marker of diffuse white matter pathology in MRI-negative TLE, modulated by demographic factors. Consistent sex effects across groups indicate biological rather than disease-specific variation. Demographic adjustment improves specificity but not overall accuracy, supporting PSMD for group-level cross-sectional studies. Sex effects must be controlled for in white-matter diffusion MRI.
Indexed as
Identifiers
41724833What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.